Andromeda/Teva/Clal DiaPep277 Data from the first phase III trial are expected next month. A free full text review on the area: http://www.discoverymedicine.com/Dequina-Nicholas/2011/04/07/autoantigen-based-vaccines-for-type-1-diabetes/